Both companies have requested the FDA add semaglutide and tirzepatide, respectively, to its lists of drug products that present demonstrable difficulties for compounding. These DDC Lists identify substances that are considered particularly risky to compound, and drugs on these lists cannot be compounded under either 503A or 503B which could be the biggest problem for companies like Hims
How do GLP-1 receptor agonists reduce cardiovascular risks in patients with a history of atherosclerotic cardiovascular disease (ASCVD), and why might these benefits be significant for long-term patient care
The Long-Term Safety Context A common concern when a medication has only been around for a year or two is long-term safety
The evidence for this is poor and expert opinion suggests as long as you have enough weight to lose, that your milk should be unaffected (Hale)
Start Your Online GLP-1 Weight Loss Journey If you are exploring one of the best online weight loss programs in Texas, visit MedLeanRx to learn more about physician-guided semaglutide and tirzepatide treatment options
Eating protein helps stimulate muscle protein synthesis, which is a process that builds and repairs muscle tissue